Ciencias de la Salud
Campo de conocimiento
National Institutes of Health
Bethesda, Estados UnidosPublicaciones en colaboración con investigadoras/es de National Institutes of Health (26)
2024
-
A genome-wide association meta-analysis of all-cause and vascular dementia
Alzheimer's and Dementia, Vol. 20, Núm. 9, pp. 5973-5995
2021
-
Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia
Neuropsychopharmacology, Vol. 46, Núm. 3, pp. 665-672
-
Exome-wide rare variant analysis in familial essential tremor
Parkinsonism and Related Disorders, Vol. 82, pp. 109-116
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease
Annals of Neurology, Vol. 90, Núm. 1, pp. 35-42
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Targeting myosin 1c inhibits murine hepatic fibrogenesis
American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 320, Núm. 6, pp. G1044-G1053
2020
-
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma
Blood, Vol. 135, Núm. 4, pp. 274-286
-
Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis
Journal of Clinical Immunology, Vol. 40, Núm. 6, pp. 901-916
2018
-
Expression profiling analysis reveals key Microrna-mRNA interactions in early retinal degeneration in retinitis pigmentosa
Investigative Ophthalmology and Visual Science, Vol. 59, Núm. 6, pp. 2381-2392
-
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures
Cell, Vol. 174, Núm. 6, pp. 1559-1570.e22
2016
2015
-
Design and evaluation of surface and adjuvant modified PLGA microspheres for uptake by dendritic cells to improve vaccine responses
International Journal of Pharmaceutics, Vol. 496, Núm. 2, pp. 371-381
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 385, Núm. 9963, pp. 117-171
-
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 10010, pp. 2287-2323
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition
The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 9995, pp. 743-800
2014
-
MicroRNAs and cholestatic liver diseases
Current Opinion in Gastroenterology, Vol. 30, Núm. 3, pp. 303-309